In the present study, both doses of AZIL and/or AD-MSCs were able to counteract ROS and reduce LP by lowering the MDA level in parallel with elevating the levels of GSH and SOD, implying a significant improvement of antioxidant defenses. This evidence concerns the gene SOD1 and Alzheimer disease.